Cooper AM (2009) Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 27:393–422
Article PubMed PubMed Central CAS Google Scholar
Kaufmann SHE (2016) EFIS lecture. Immune response to tuberculosis: How to control the most successful pathogen on earth. Immunol Lett 175:50–57
Article PubMed CAS Google Scholar
Light RW (2010) Update on tuberculous pleural effusion. Respirology 15:451–458
Mitra DK, Sharma SK, Dinda AK et al (2005) Polarized helper T cells in tubercular pleural effusion: phenotypic identity and selective recruitment. Eur J Immunol 35:2367–2375
Article PubMed CAS Google Scholar
Bozza VV, D’Attilio L, Mahuad CV et al (2007) Altered cortisol/DHEA ratio in tuberculosis patients and its relationship with abnormalities in the mycobacterial-driven cytokine production by peripheral blood mononuclear cells. Scand J Immunol 66:97–103
Article PubMed CAS Google Scholar
Santucci N, D’Attilio L, Kovalevski L et al (2011) A Multifaceted Analysis of Immune-Endocrine-Metabolic Alterations in Patients with Pulmonary Tuberculosis. PLoS ONE 6:e26363
Article PubMed PubMed Central CAS Google Scholar
D’Attilio L, Díaz A, Fernández RDV et al (2018) The neuro-endocrine-immune relationship in pulmonary and pleural tuberculosis: a better local profile in pleural fluid. Int J Tuberc Lung Dis 22:321–327
Cerliani JP, Blidner AG, Toscano MA et al (2017) Translating the ‘Sugar Code’ into immune and vascular signaling programs. Trends Biochem Sci 42:255–273
Article PubMed CAS Google Scholar
Cooper D (2002) Galectinomics: finding themes in complexity. Biochim Biophys Acta BBA - Gen Subj 1572:209–231
Rabinovich GA, Toscano MA (2009) Turning ‘sweet’ on immunity: galectin–glycan interactions in immune tolerance and inflammation. Nat Rev Immunol 9:338–352
Article PubMed CAS Google Scholar
Toscano MA, Martínez Allo VC, Cutine AM et al (2018) Untangling galectin-driven regulatory circuits in autoimmune inflammation. Trends Mol Med 24:348–363
Article PubMed CAS Google Scholar
Matarrese P, Tinari A, Mormone E et al (2005) Galectin-1 sensitizes resting human T lymphocytes to Fas (CD95)-mediated cell death via mitochondrial hyperpolarization, budding, and fission. J Biol Chem 280:6969–6985
Article PubMed CAS Google Scholar
Díaz-Alvarez L, Ortega E (2017) The many roles of galectin-3, a multifaceted molecule, in innate immune responses against pathogens. Mediators Inflamm 2017:1–10
Liu F, Rabinovich GA (2010) Galectins: regulators of acute and chronic inflammation. Ann N Y Acad Sci 1183:158–182
Article PubMed CAS Google Scholar
Rabinovich GA, Daly G, Dreja H et al (1999) Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 190:385–398
Article PubMed PubMed Central CAS Google Scholar
Perone MJ, Bertera S, Shufesky WJ et al (2009) Suppression of autoimmune diabetes by soluble galectin-1. J Immunol 182:2641–2653
Article PubMed CAS Google Scholar
Poncini CV, Ilarregui JM, Batalla EI et al (2015) Trypanosoma cruzi infection imparts a regulatory program in dendritic cells and T cells via Galectin-1–dependent mechanisms. J Immunol 195:3311–3324
Article PubMed CAS Google Scholar
Benatar AF, García GA, Bua J et al (2015) Galectin-1 prevents infection and damage induced by Trypanosoma cruzi on cardiac cells. PLoS Negl Trop Dis 9:e0004148
Article PubMed PubMed Central Google Scholar
Morrison HM, Craft J, Rivera-Lugo R et al (2023) Deficiency in galectin-3, -8, and -9 impairs immunity to chronic Mycobacterium tuberculosis infection but not acute infection with multiple intracellular pathogens. PLoS Pathog 19:e1011088
Article PubMed PubMed Central CAS Google Scholar
Gallucci G, Díaz A, Fernandez RDV et al (2022) Differential expression of genes regulated by the glucocorticoid receptor pathway in patients with pulmonary tuberculosis. Life Sci 301:120614
Article PubMed CAS Google Scholar
Zacarías Fluck MF, Hess L, Salatino M et al (2012) The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide. Cancer Immunol Immunother 61:469–480
D’Attlio L, Trini E, Bongiovanni B et al (2011) mRNA expression of alpha and beta isoforms of glucocorticoid receptor in peripheral blood mononuclear cells of patients with tuberculosis and its relation with components of the immunoendocrine response. Brain Behav Immun 25:461–467
He J-Q, Sandford AJ, Wang I-M et al (2008) Selection of housekeeping genes for real-time PCR in atopic human bronchial epithelial cells. Eur Respir J 32:755–762
Gallucci G, Santucci N, Díaz A et al (2021) Increased levels of circulating LPS during Tuberculosis prevails in patients with advanced pulmonary involvement. PLoS One 16:e0257214
Article PubMed PubMed Central CAS Google Scholar
Vorster MJ, Allwood BW, Diacon AH et al (2015) Tuberculous pleural effusions: advances and controversies. J Thorac Dis. https://doi.org/10.3978/j.issn.2072-1439.2015.02.18
Article PubMed PubMed Central Google Scholar
D’Attilio L, Díaz A, Santucci N et al (2013) Levels of inflammatory cytokines, adrenal steroids, and mRNA for GRα, GRβ and 11βHSD1 in TB pleurisy. Tuberculosis 93:635–641
Sundblad V, Morosi LG, Geffner JR et al (2017) Galectin-1: a jack-of-all-trades in the resolution of acute and chronic inflammation. J Immunol 199:3721–3730
Article PubMed CAS Google Scholar
Souza BSDF, Silva DN, Carvalho RH et al (2017) Association of cardiac Galectin-3 expression, myocarditis, and fibrosis in chronic Chagas disease cardiomyopathy. Am J Pathol 187:1134–1146
Article PubMed CAS Google Scholar
Liu F-T, Stowell SR (2023) The role of galectins in immunity and infection. Nat Rev Immunol 23:479–494
Article PubMed CAS Google Scholar
Chou F-C, Chen H-Y, Kuo C-C et al (2018) Role of galectins in tumors and in clinical immunotherapy. Int J Mol Sci 19:430
Article PubMed PubMed Central Google Scholar
Troncoso MF, Elola MT, Blidner AG et al (2023) The universe of galectin-binding partners and their functions in health and disease. J Biol Chem 299:105400
Article PubMed PubMed Central CAS Google Scholar
Bongiovanni B, Marín-Luevano S, D’Attilio L et al (2020) Evidence that changes in antimicrobial peptides during tuberculosis are related to disease severity, clinical presentation, specific therapy and levels of immune-endocrine mediators. Cytokine 126:154913
Comments (0)